Our mutant epitope-specific antibody screening utilizes advanced yeast display technology to identify and isolate antibodies that specifically target mutant epitopes, which arise from genetic mutations in proteins. These mutations cause alterations in the antigenic structure, making the mutant epitopes often unrecognizable to conventional antibodies. This makes detecting mutant epitopes crucial for the development of targeted therapies and diagnostic tools for diseases like cancer, infectious diseases, and autoimmune disorders, where specific mutations play a key role in disease progression and resistance to treatment.
Yeast display technology offers an efficient and effective means of discovering antibodies that bind precisely to these unique mutated structures. This approach enables the identification of antibodies with higher sensitivity and specificity, which is essential for the development of personalized treatments. By focusing on these specific mutations, our service ensures that antibodies can effectively recognize and target the mutant forms, addressing the challenges that standard antibodies may face. Our comprehensive service not only discovers but also optimizes epitope-specific antibodies, providing a robust solution for therapeutic and diagnostic applications.
Species | Antibody Library ID | Display Technology | Library Format | Library Size |
VHH (Llama) | LlaVHH-YDP-1 | Yeast Display | Naïve VHH | 1.5×108 |
Human | HuscL-YDP-3 | Yeast Display | Naïve scFv | 1.9×108 |
From immune antibody screening to targeting cell-based assays and specific epitopes, we provide the tools and support necessary for your project's success. For further information, please visit the services below:
Premade Yeast Display SdAb Library Screening
Premade Yeast Display ScFv Library Screening
Yeast Display Immune Antibody Library Screening
Yeast Display Antibody Library Screening for Cell-based Target
Yeast Display Library Screening for TCR-Like Antibody
Yeast Display Library Screening for Anti-GPCR Antibody
Yeast Display Library Screening for pH-Dependent Antibody
- Creation of highly diverse antibody libraries and library capacity over 109.
- Identifies antibodies with high specificity for mutant epitopes.
- Enables high-throughput screening to identify antibodies that target mutated antigenic sites.
- Significantly reduces the time and cost for discovering antibodies against novel or difficult targets.
- Tailored services to target specific mutant epitopes.
- Ensures that identified antibodies are optimized for the unique characteristics of the target.
- Accelerates the discovery process by screening a vast library of antibody candidates.
- Includes affinity maturation and optimization to ensure high-affinity, functional antibodies.
- Ideal for discovering antibodies against mutated antigens in cancer, infectious diseases, and autoimmune disorders.
- Enables the development of more effective targeted therapies and diagnostic tools for these diseases.
By choosing our mutant epitope-specific antibody screening service, you gain access to a powerful tool in the antibody discovery process, essential for advancing targeted therapies and diagnostics. Our team will help you navigate the complexities of mutant epitope recognition with precision and confidence.
today to discuss your specific requirements and take the next step in antibody innovation!All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
USA:
Europe: Germany: |
|
Call us at: USA: UK: Germany: |
|
Fax:
|
|
Email: info@creative-biolabs.com |